California PDMP Enhancement, Analysis and Response Initiative

Similar documents
Prescription Drug Monitoring Program

Harold Rogers Update Melissa McPheeters, PhD, MPH

COLORADO PRESCRIPTION DRUG MONITORING PROGRAM

The Wisconsin Prescription Drug Monitoring Program

The Wisconsin Prescription Drug Monitoring Program. WI PDMP Timeline. PDMP Overview. What is a PDMP? PDMPs Across the Nation. Wisconsin.

Michigan Legislative and Regulatory Pharmacy Initiatives Update

Data-Driven Multidisciplinary Approaches to Reduce Prescription Drug Abuse in Kentucky

4/26/2018. Bureau of Professional Licensing. MAPS Updates & Opportunities. MAPS Background. Registration. MAPS Update

Addressing Prescription Drug Abuse. Allan Coukell Senior Director, Drugs and Medical Devices The Pew Charitable Trust

VIRGINIA S OPIOID & HEROIN OVERDOSE EPIDEMIC

SAFE OPIOID PRESCRIBING C.U.R.E.S. PROGRAM

MANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN. State Senator Alberta Darling

PDMP Track: Linking and Mapping PDMP Data. Gillian Leichtling Acumentra Health Chris Baumgartner, WA State Dept. of Health

Tom Williams, MD Chief Medical Officer Director of the Division of Public Health Nebraska Department of Health and Human Services

Comprehensive Opioid Abuse Program (COAP) Category 6 Grantees Call

Prescription Behavior Surveillance System Len Paulozzi, MD, MPH

Project Update: Comparing South Dakota Prescription Drug Monitoring Program Law Enforcement Profile Requests to Criminal History Data

Illinois Prescription Monitoring Program. Sarah Pointer, Pharm D. Clinical Director of the Illinois Prescription Monitoring Program

Prescription Monitoring Program Center for Excellence, Brandeis University. April 10-12, 2012 Walt Disney World Swan Resort

The Oregon Opioid Initiative. State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division

Meth and Opioid Abuse Prevention Efforts

CDC s Approach to Addressing the Opioid Overdose Epidemic

Prescription Medication Guidelines for Medical Providers in CorVel s CorCare and Care IQ Networks

Using PDMP Data to Guide Interventions with Possible At-Risk Prescribers

4/10/2016. Legal & Policy Approaches to Reducing Opioid Poisonings. Overview. Background. Health Directors Legal Conference April 19, 2016

California Hub and Spoke System Evaluation

D. Todd Bess, PharmD 1

Washington State PMP Data Mapping Project

Harold Rogers Prescription Drug Monitoring Program National Meeting. August 17, 2016

4/24/15. New Mexico s Prescription Monitoring Program. Carl Flansbaum, RPh. PMP Director New Mexico Board of Pharmacy. New Mexico and the PMP

Using Prescription Drug Monitoring Program Data to Advance Prevention Planning

EXECUTIVE ORDER TAKING FURTHER ACTIONS TO ADDRESS THE OPIOID OVERDOSE CRISIS

Harold Rogers Prescription Drug Monitoring Program Regional Meeting-Charleston, SC April 29, 2014 Andrew Holt, PharmD

Opioid Abuse in Iowa Rx to Heroin. Iowa Governor s Office of Drug Control Policy January 2016

October 20, 2016 Scott K. Proescholdbell, MPH. Opioid Overdose and North Carolina s Public Health and Prevention Strategies

EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC

Do you CARA? A Deep Dive Into the Comprehensive Addiction and Recovery Act Joel White, President

Using the NC Controlled Substances Reporting System to Identify Providers Manifesting Unusual Prescribing Practices

Aligning Pain Management Community Public Health Presentation

Hospitals Role in Addressing the Opioid Crisis

Ranked in the top 10% in: -Low percent of adults reporting fair or poor health

Performance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q)

Washington State s Overdose Epidemic

Collaborative for Effective Prescription Opioid Policies

Wednesday, June 21, Dear Chairmen and Ranking Members:

Outline. Decreasing total opioid prescriptions Decreasing benzodiazepine and opioid co-prescription. Increasing community awareness of opioid risks

Report to the Legislature: Recommendations on Required Use and Other Uses of the MN Prescription Monitoring Program Database

Prescription Drug Monitoring Program Update. Rebecca R. Poston, BPharm., MHL Program Manager August 26, 2017

Prescription Drug Abuse and Heroin: Impact on Oregon s Youth and Young Adults

Building a Comprehensive, Community-driven Prevention Approach to the Opioid Crisis in Maine

Data Integration and Analysis for Improved Drug Overdose Surveillance in Kentucky

Safe States Alliance 2018 Innovative Initiatives Finalist Summaries for Review

September 1, The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201

Prescription Drug Abuse National Perspective

Successful Prevention Strategies to Address the Opioid Crises

BJA COAP Category 6 Quarterly Webinar November 29, 2018

Targeting an Epidemic: Opioid Prescribing Patterns by County in New York State

Tri-County Region Opioid Trends Clackamas, Multnomah, and Washington, Oregon. Executive Summary

The Criminal Justice Response to Opioid Trafficking in Michigan

The National Association of State Alcohol and Drug Abuse Directors (NASADAD) FY 2018 Appropriations

Technical Assistance Guide No Recommended PDMP Reports to Support Licensing/Regulatory Boards and Law Enforcement Investigations

Prescription Drug Monitoring Programs and Other State-Level Strategies

STATE & FEDERAL EFFORTS TO COMBAT THE OPIOID EPIDEMIC & IMPACT ON COMPLIANCE PROGRAMS GRACE E. REBLING OSBORN MALEDON P.A.

Key Findings and Recommendations from the

Opioid Use and Other Trends

5/16/2016. Roadmap. Legal Competencies. Prescription Drug Overdose at Epidemic Levels

Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities

Data Driven Justice Incarceration Report

What do we mean by the opioid crisis? Painkiller prescriptions per 100 North Carolinians Source: CDC US Prescribing Rate Maps (2016)

ACCG Mental Health Summit

STATE OF CALIFORNIA STRATEGIES TO ADDRESS PRESCRIPTION DRUG (OPIOID) MISUSE, ABUSE, AND OVERDOSE EPIDEMIC IN CALIFORNIA

PDMP Tools to Identify Red Flag Situations

C U S T O M E R D R I V E N. B U S I N E S S M I N D E D.

Is Data the Answer to Getting a Handle on Prescription Drug Abuse?

Opioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative

Public Health Federal Funding Request to Address the Opioid Epidemic

Reducing Opioid Deaths: Arizona s Emergency Declaration & Response

Data-Driven Prevention Initiative

Kentucky All Schedule Prescription Electronic Reporting (KASPER)

Opioid Overdose in Oregon Report to the Legislature

Prescription Opioid Overdose in Oregon: A public health perspective

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention

SUBJECT: Opioid Overdose and Intranasal Naloxone Training for Law Enforcement: Train the Trainer Session: Queens County October 17, 2014

Arkansas Department of Health

Maine PMP Update. Daniel Eccher, MPH MPA Convention May 20, 2011

Kansas Prescription Drug and Opioid Advisory Committee

Pennsylvania s Opioid Crisis: Data and Strategies to Combat It

Medicare Advantage Outreach and Education Bulletin

ASTHO President s Challenge 15 x 15: Reduce Prescription Drug

RX Drug Abuse Prevention in Nevada

Pennsylvania Prescription Drug Monitoring Program Trends,

Prescription Drugs: Issues in Treatment, Supervision and Case Management

PROJECT DOVE. Improving Maternal and Neonatal Health Through Safer Opioid Prescribing

Data for Disparities Impact Statement November 2016

Reducing Opioid Over- Prescribing in a Large Integrated Health Care System

Wisconsin Statewide Substance Abuse Prevention Training Wisconsin Dells June 12, 2015

Facing the Opioid Epidemic (FOE): Assessing and Responding to Prescription and Illicit Opioid Use and Misuse in 5 New England States

Submitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis

Opioid Response Package Awaits President s Signature Trinity Tomsic

Overdose Detection Mapping Application Program (ODMAP) ATLANTA-CAROLINAS HIGH INTENSITY DRUG TRAFFICKING AREA (HIDTA)

Transcription:

California PDMP Enhancement, Analysis and Response Initiative California Department of Justice University of California Davis Harold Rogers PDMP National Meeting August 15-16, 2016

Outline 1. Project overview 2. Evaluating de-duplication of PDMP data 3. Integrating PDMP and hospital / emergency department data 4. Integrating data from other states

CURES 2.0 California SB 809 (stats 2013, Chapter 400, DeSaulnier) was signed by the Governor on September 27, 2013: 1. Re-funded PDMP operations 2. Mandatory provider registration by July 1, 2016 3. Enabled CA DOJ to add advanced features: Updated user interface Automatic (unsolicited) alerts within PDMP Ability to send peer-to-peer messages within PDMP

California Harold Rogers Grant Partnership between California DOJ and UC Davis researchers Evaluate implementation and effect of CURES 2.0 on prescribing practices drug overdose rates Optimize PDMP utility by coordinating with public health, regulatory, and law enforcement agencies Design and test data-driven algorithms for identifying high-risk prescribing and dispensing patterns

De-duplication of PDMP data Purpose: to identify prescriptions for the same individual Challenges No unique patient identifier Variation in identifying data for an individual Hundreds of millions of records

Example First Name Last Name Sex DOB Address Zip Code Stephen Henry Male 05/11/77 2450 48 th Street 95817 Steven Henry Male 05/11/77 2450 48 th St. 95817 Henry Stevens Male 11/05/77 2450 48 th St., Apt. 2 95817 Steve Henry Male 05/11/87 2405 48 th Street 95807 Are these the same person?

Strategy: Compare record linkage programs CURES 2.0 custom built program SAS application The Link King: http://www.the-link-king.com/index.html SAS application Link Plus: http://www.cdc.gov/cancer/npcr/tools/registryplus/lp.htm Microsoft Windows stand-alone application LinkSolv: http://www.strategicmatching.com/products.html Microsoft Access application

Determine for each program Blocking variables What matches to consider Cut-points for probabilistic matches How good does the match have to be Feasibility program run times, ease of use

Comparison procedure Stratify data by certainty of linkage From high to low probability of a match 4 reviewers will inspect a stratified random sample of matches Identity of the program and certainty of the match is withheld Truth determined by majority opinion

Statistics to compare Sensitivity: proportion of true matches identified by the program Specificity: proportion of true non-matches identified by the program Positive predictive value: proportion of identified matches that are true matches Negative predictive value: proportion of identified non-matches that are true nonmatches Area under ROC curve

Goals Determine which program is most accurate and feasible to use in production Inform best practices for PDMP record linkage

Integrating PDMP & outcome data

Analysis plan time series Track data from multiple sources PDMP registration & use (CURES) Prescribing patterns (CURES) Hospitalization & emergency department visits related to opioid-overdose (OSHPD) Overdose deaths (CDPH) Identify major events (e.g., mandatory PDMP registration) to estimate the effect on the indicators

Follow Counties Over Time Include county indicators into the time series. Explore each county s contribution to overlying trends.

Integrating data from other states Extend time series by including prescribing and overdose data from other states without the specific enhanced PDMP features of CURES 2.0 Compare trends in California counties (intervention group) with counties in other PBSS states (control group) Takes into account potential changes affecting both groups (e.g., national policy trends)

Analysis plan Estimate the effect CURES 2.0 enhancements on prescribing practices, fatal overdoses, and non-fatal overdose. Use data from PBSS, NSDUH, & CDC WONDER Use a difference-in-difference approach to isolate effects associated with CURES 2.0 enhancements.

Example 1: Time series analysis (single group) 0 5 10 15 20 25 30 Intervention starts Apparent effect of the intervention 1 3 5 7 9 11 13 15 17 19 21 Time Rate intervention group

0 5 10 15 20 25 30 Example 2: Time series analysis (with comparison group) Intervention starts No effect of the intervention. Something else could have happened at the same intervention period affecting both groups 1 3 5 7 9 11 13 15 17 19 21 Time Rate intervention group Rate control group

Questions California Department of Justice Mike Small (mike.small@doj.ca.gov) Tina Farales (tina.farales@doj.ca.gov) University of California Davis Stephen Henry (sghenry@ucdavis.edu) Alvaro Castillo (alvacasti@gmail.com)